KÖKLÜ, H. Et Al. 2018. Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Therapy-Related Severe Anemia. ANNALS OF PHARMACOTHERAPY , vol.52, no.4 , 397-398.

KÖKLÜ, H., PÜRNAK, T., Tseveldorj, N., ALTAN, E., & ŞİMŞEK, H., (2018). Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Therapy-Related Severe Anemia. ANNALS OF PHARMACOTHERAPY , vol.52, no.4, 397-398.

KÖKLÜ, HAYRETDİN Et Al. "Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Therapy-Related Severe Anemia," ANNALS OF PHARMACOTHERAPY , vol.52, no.4, 397-398, 2018

KÖKLÜ, HAYRETDİN Et Al. "Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Therapy-Related Severe Anemia." ANNALS OF PHARMACOTHERAPY , vol.52, no.4, pp.397-398, 2018

KÖKLÜ, H. Et Al. (2018) . "Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Therapy-Related Severe Anemia." ANNALS OF PHARMACOTHERAPY , vol.52, no.4, pp.397-398.

@article{article, author={HAYRETDİN KÖKLÜ Et Al. }, title={Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Therapy-Related Severe Anemia}, journal={ANNALS OF PHARMACOTHERAPY}, year=2018, pages={397-398} }